background
mitogenactiv
protein
kinas
mapk
pathway
play
essenti
role
diseas
previous
demonstr
potenti
inhibitori
effect
locat
upstream
mapk
upregul
mous
heart
upon
infect
howev
effect
underli
mechan
infect
remain
unclear
detect
continu
chang
cellular
mapk
protein
express
profil
post
infect
vitro
within
h
mapk
signal
inhibit
specif
inhibitor
small
interf
rna
mimic
vitro
replic
cell
apoptosi
rate
prolifer
detect
viral
load
mice
heart
cardiomyocyt
apoptosi
rate
histolog
heart
also
detect
mice
model
viral
myocard
pretreat
observ
signific
upregul
express
follow
suppress
mapk
signal
hela
cell
inactiv
mapk
signal
mapk
specif
inhibitor
small
interf
rna
overexpress
significantli
inhibit
viral
progeni
releas
cell
mechanist
compar
control
mirna
show
effect
capsid
protein
express
viral
load
within
host
cell
significantli
revers
activ
cell
apoptosi
rate
promot
prolifer
infect
cell
indic
inhibitori
effect
progeni
releas
vivo
studi
compar
control
mirna
pretreat
remark
inactiv
mapk
signal
mice
protect
infect
evidenc
significantli
allevi
cell
apoptosi
rate
reduc
viral
titer
necrosi
heart
well
remark
prolong
surviv
time
conclus
revers
correl
mapk
activ
post
infect
overexpress
significantli
inhibit
viral
progeni
releas
decreas
myocyt
apoptosi
rate
vitro
vivo
suggest
may
serv
potenti
therapeut
agent
infect
target
mapk
signal
coxsackieviru
common
import
pathogen
viral
myocard
pancreat
asept
mening
young
children
infant
infect
may
lead
acut
heart
failur
sudden
death
due
direct
cytopath
effect
induc
viral
replic
earli
phase
infect
viru
elimin
vital
organ
consid
key
therapeut
strategi
treat
diseas
howev
current
avail
drug
treatment
infect
broadspectrum
antivir
drug
limit
efficaci
therefor
understand
mechan
involv
infect
may
provid
new
clue
develop
novel
therapeut
strategi
diseas
mitogenactiv
protein
kinas
mapk
famili
protein
kinas
involv
convert
extracellular
stimuli
intracellular
respons
accumul
evid
demonstr
numer
virus
includ
activ
mapk
subfamili
facilit
inflammatori
respons
apoptosi
viral
replic
infect
cell
mapk
inhibitor
suppress
hela
cell
apoptosi
viral
progeni
releas
suggest
mapk
signal
essenti
cytopath
effect
life
cycl
infect
cell
pharmacolog
inhibit
mapk
phosphoryl
shown
effect
suppress
replic
releas
vitro
vivo
addit
one
direct
upstream
activ
mapk
h
post
human
cytomegaloviru
infect
increas
activ
critic
maintain
activ
necessari
viral
dna
replic
therefor
target
mapk
signal
would
promis
therapeut
approach
infect
microrna
mirna
small
noncod
rna
molecul
posttranscript
inhibit
gene
express
bind
specif
sequenc
within
untransl
region
target
mrna
previou
report
demonstr
mani
virus
encod
mirna
exploit
host
mirna
modul
host
andor
viral
gene
express
exampl
kaposi
sarcomaassoci
herpesviru
encod
mirna
precursor
gener
matur
mirna
share
seed
sequenc
host
mirna
target
host
mrna
involv
immun
respons
addit
human
immunodefici
viru
type
induc
specif
target
infect
cell
modul
life
cycl
base
mirnamedi
hostviru
interact
use
mirna
target
mechan
promot
viral
infect
replic
emerg
promis
antivir
strategi
feasibl
demonstr
sever
studi
suppress
pyruv
kinas
liver
red
blood
cell
inhibit
pyruv
product
critic
hepat
b
c
viru
replic
mimic
target
mapk
signal
exhibit
antivir
effect
influenza
respiratori
syncyti
viru
infect
previou
studi
found
upregul
heart
tissu
mice
myocard
play
import
role
cardiovascular
develop
dysregul
variou
cardiovascular
diseas
cardiac
hypertrophi
fibrosi
myocardi
infarct
interestingli
direct
target
mimic
effect
inhibit
express
hepatocellular
carcinoma
thu
hypothes
might
involv
mapk
signal
infect
present
studi
found
may
exert
protect
role
infect
hela
cell
mous
model
target
mapk
signal
pathway
find
may
enrich
understand
function
underli
mechan
diseas
provid
potenti
therapeut
approach
treatment
infect
strain
gener
gift
decheng
yang
univers
british
columbia
british
columbia
canada
passag
hela
cell
male
balbc
mice
technolog
matur
mirna
level
detect
taqman
microrna
assay
life
technolog
use
rel
quantit
method
describ
previous
rna
detect
endogen
control
data
normal
revers
transcript
primer
ctc
aac
tgg
tgt
cgt
gga
gtc
ggc
aat
tca
gtt
gag
tca
aca
sens
antisens
primer
ctc
cag
ctg
gct
agc
tta
tca
gac
tga
aac
tgg
tgt
cgt
gga
qrtpcr
experi
repeat
triplic
notempl
control
cell
seed
plate
per
well
h
transfect
mutant
human
target
transfect
cell
simultan
ng
wildtyp
mutant
plasmid
use
lipofectamin
invitrogen
carlsbad
ca
accord
manufactur
instruct
luciferas
activ
measur
use
dualluciferas
report
assay
system
promega
madison
h
transfect
rel
luciferas
activ
valu
achiev
renilla
control
hela
cell
grown
complet
medium
dmem
supplement
newborn
calf
serum
confluenc
prior
infect
hela
cell
infect
multipl
infect
moi
unless
otherwis
indic
sham
infect
phosphatebuff
salin
pb
h
serumfre
dmem
cell
wash
pb
cultur
complet
medium
indic
period
time
ontarget
plu
smart
pool
sirna
contain
sirna
purchas
dharmacon
lafayett
co
usa
transfect
hela
cell
use
lipofectamin
final
concentr
nm
accord
manufactur
instruct
sirna
unrel
human
genom
also
use
control
medium
replac
h
infect
carri
h
later
moi
mapk
inhibitor
purchas
medchem
express
hela
cell
treat
min
infect
moi
gener
lentivir
vector
overexpress
oligonucleotid
forward
gat
ccc
cgg
gta
ccg
gtt
tat
caa
atc
ctg
cct
revers
primer
aca
ttc
cac
agg
cta
gac
cag
aca
gaa
gga
cca
synthes
base
sequenc
human
mirbas
databas
oligonucleotid
introduc
pgcsilgfp
plasmid
genechem
co
ltd
shanghai
china
construct
lentiviru
phelper
phelper
purchas
shanghai
genechem
co
ltd
gener
lentiviru
viral
titrat
evalu
conduct
describ
previous
lentiviru
contain
sequenc
design
lentiviru
contain
mirna
sequenc
identifi
target
mammalian
cell
also
construct
control
design
lenticon
hela
cell
transduc
moi
infect
carri
h
later
moi
suscept
mice
transduct
unit
intraven
inject
mous
via
caudal
vein
mice
inocul
intraperiton
dose
plaqu
form
unit
pfu
viru
per
mice
mice
monitor
daili
onset
paralysi
surviv
mice
euthan
day
infect
n
per
group
experi
carri
time
express
heart
mice
excis
mous
heart
weigh
homogen
total
rna
obtain
homogen
cell
trizol
reagent
follow
procedur
forement
activ
assay
measur
accord
manufactur
suggest
r
system
hela
cell
transduc
moi
follow
infect
moi
h
later
h
post
infect
cell
lysat
harvest
subject
activ
assay
use
fluorogen
substrat
cell
viabil
measur
use
mt
assay
kit
promega
madison
accord
manufactur
instruct
hela
cell
transduc
infect
incub
mt
solut
h
indic
time
point
absorb
measur
nm
use
micropl
reader
surviv
valu
absorb
measur
control
cell
defin
valu
obtain
infect
cell
convert
ratio
base
valu
control
sampl
detect
viral
titer
supernat
hela
cell
collect
h
h
h
post
infect
cell
debri
discard
centrifug
min
rpm
detect
viral
titer
within
hela
cell
lysat
infect
cell
collect
previous
describ
briefli
cell
trypsin
h
postinfect
count
follow
pb
rins
centrifug
min
cell
pellet
resuspend
ml
dmem
contain
fetal
calf
serum
subject
three
freezethaw
cycl
use
liquid
nitrogen
heat
block
set
sampl
centrifug
min
remov
cell
debri
detect
viral
load
tissu
heart
mice
weigh
homogen
ml
mem
centrifug
rpm
min
viral
titer
supernat
cell
lysat
infect
tissu
analyz
viral
plaqu
assay
previous
describ
express
pfuml
cell
gram
respect
assess
sever
myocard
paraffinembed
section
heart
tissu
stain
hematoxylineosin
examin
histopatholog
evid
inflamm
necrosi
assess
apoptosi
cardiomyocyt
tunel
assay
immunohistochemistri
stain
cleav
caspas
perform
tunel
apoptosi
assay
kit
beyotim
technolog
china
anticleav
caspas
monoclon
antibodi
cell
signal
technolog
inc
china
follow
manufactur
instruct
describ
previous
cell
pool
pellet
centrifug
wash
icecold
pb
resuspend
bind
buffer
mm
hepesnaoh
ph
mm
nacl
mm
cacl
concentr
ml
ml
cell
suspens
transfer
tube
incub
annexinv
pi
min
dark
sampl
analyz
flow
cytometri
within
h
facscan
flow
cytomet
bd
bioscienc
result
present
percentag
earli
apoptot
annexinv
pi
late
apoptot
annexinv
pi
hela
cell
homogen
mice
heart
tissu
collect
indic
time
point
lyse
ripa
buffer
kangwei
beij
china
antibodi
detect
mapk
mapk
hsp
phsp
cleav
bax
gapdh
purchas
cell
signal
technolog
cell
signal
technolog
inc
china
antibodi
detect
viral
purchas
leica
biosystem
newcastl
western
blot
conduct
describ
previous
statist
analys
perform
use
spss
comput
softwar
program
spss
inc
chicago
il
surviv
analyz
use
logrank
mantelcox
method
signific
variabl
among
experiment
group
determin
mannwhitney
u
test
differ
consid
statist
signific
p
previou
studi
perform
express
profil
cellular
mirna
heart
mice
determin
overexpress
acut
stage
infect
hela
cell
moi
assess
level
post
infect
realtim
pcr
result
confirm
increas
infect
approxim
almost
h
fig
infect
hela
cell
lead
activ
mapk
downstream
determin
whether
induc
upregul
could
affect
level
examin
continu
chang
express
upon
infect
upregul
significantli
h
post
cvb
infect
sustain
high
level
h
post
infect
howev
express
level
drop
h
fig
seem
result
high
level
line
previou
vivo
result
assess
effect
associ
pathway
examin
phosphoryl
mapk
phosphoryl
heat
shock
protein
downstream
substrat
mapk
pathway
found
express
almost
accord
high
level
h
decreas
h
fig
bioinformat
analysi
suggest
candid
target
fig
assess
possibl
perform
luciferas
report
assay
cell
mimic
specif
reduc
activ
report
contain
effect
appar
control
mirna
mutat
target
fig
basi
find
conclud
particip
infect
process
potenti
inhibit
express
fig
detect
supernat
found
inhibit
activ
induc
signific
reduct
viral
progeni
releas
fig
evalu
role
hela
cell
use
sirna
specif
knock
infect
moi
h
later
inhibit
mapk
express
evalu
h
post
infect
commonli
peak
express
fig
found
express
attenu
cell
fig
furthermor
titer
decreas
supernat
treat
cell
h
h
fig
result
suggest
mapk
particip
replic
process
inhibit
could
reduc
mapk
express
viral
progeni
releas
given
high
express
infect
process
abil
target
reason
express
exogen
might
provid
approach
amelior
effect
infect
investig
possibl
construct
lentiviru
contain
sequenc
design
lentiviru
contain
mirna
identifi
target
mammalian
cell
design
lenticon
hela
cell
infect
moi
day
post
transduct
lentiviru
express
upregul
fig
expect
mapk
level
reduc
group
compar
lenticon
group
h
post
infect
total
mapk
level
chang
fig
evalu
whether
exogen
restrain
releas
hela
cell
collect
supernat
perform
viral
plaqu
assay
found
viral
load
significantli
decreas
post
infect
fig
infect
replic
cell
may
caus
cytopath
effect
eventu
cell
death
last
step
life
cycl
enteroviru
releas
viral
progeni
medium
investig
whether
progeni
releas
due
suppress
replic
detect
express
capsid
protein
infect
hela
cell
h
follow
infect
shown
fig
protein
level
compar
control
group
consist
signific
chang
observ
viral
load
within
mirnacontransfect
hela
cell
h
h
post
infect
fig
result
suggest
viral
replic
cell
affect
least
within
h
post
infect
consid
decreas
viral
progeni
releas
may
result
inhibit
host
cell
apoptosi
mapk
activ
link
apoptot
signal
next
sought
investig
effect
apoptosi
post
infect
shown
fig
fig
effect
viral
replic
host
cell
apoptosi
prolifer
hela
cell
transduc
moi
follow
infect
moi
day
transduct
cell
transduc
lentimircon
shaminfect
cell
use
control
western
blot
assay
conduct
detect
capsid
protein
h
post
infect
repres
result
independ
experi
shown
b
intracellular
viral
titer
detect
h
post
infect
c
cell
lysat
harvest
activ
detect
use
fluorogen
substrat
indic
time
point
immunoblot
analysi
wholecel
protein
lysat
infect
cell
probe
cleavecaspas
bax
antibodi
e
induc
apoptosi
measur
annexinv
bind
extern
phosphatidylserin
repres
fac
data
annexinv
apoptot
cell
shown
cell
viabil
assay
perform
multipl
time
point
differ
amount
without
f
infect
g
viabil
hela
cell
determin
mt
assay
indic
time
point
p
infect
caus
dramat
increas
activ
mircontransfect
cell
compar
sham
infect
timedepend
manner
suggest
might
induc
apoptosi
infect
cell
importantli
could
significantli
revers
induct
effect
activ
compar
mircon
apoptosi
relat
cleavedcaspas
bax
express
h
post
infect
also
detect
found
decreas
treat
group
assay
apoptosi
rate
annexin
vfitcpi
stain
assay
found
could
inhibit
apoptosi
rate
compar
controlgroup
fig
e
result
suggest
potenti
protect
role
apoptosi
infect
cell
inde
show
effect
prolifer
uninfect
hela
cell
significantli
promot
prolifer
cell
doseand
timedepend
manner
fig
g
indic
may
protect
infect
cell
apoptosi
improv
cell
surviv
taken
togeth
result
suggest
inhibit
releas
cell
like
attribut
protect
apoptosi
least
earli
phase
infect
base
vitro
experi
hypothes
may
also
allevi
pathogenesi
mous
model
viral
myocard
evalu
possibl
inject
transduct
unit
via
caudal
vein
mice
express
confirm
dramat
upregul
heart
day
post
inject
fig
pfu
intraperiton
inocul
mice
day
titer
found
decreas
group
compar
control
group
fig
confirm
exogen
inhibit
viral
replic
also
decreas
heart
tissu
mice
consist
vitro
result
furthermor
mapk
decreas
mice
consist
role
activ
mapk
pathway
fig
explor
whether
could
inhibit
apoptosi
vivo
tunel
assay
reflect
sever
myocyt
apoptosi
immunohistochemistri
stain
cleavedcaspas
express
day
post
infect
perform
compar
control
group
percentag
tunel
posit
cell
decreas
treat
group
fig
cleavedcaspas
also
downregul
indic
function
inhibit
apoptosi
process
infect
mice
fig
determin
physiolog
outcom
overexpress
mice
examin
heart
infect
mice
cardiac
histopatholog
reveal
mice
high
express
show
minor
dropsi
hemorrhag
mice
control
group
show
signific
necrosi
sign
mononuclear
cell
infiltr
day
post
infect
fig
furthermor
surviv
rate
clearli
improv
mice
infect
fig
consist
role
attenu
infect
heart
activ
mapk
signal
pathway
essenti
infect
previou
studi
show
potenti
target
upregul
heart
mice
myocard
addit
shown
benefici
effect
myocardi
infarct
size
murin
model
howev
associ
mapk
signal
context
infect
remain
unclear
present
studi
found
may
inhibit
viral
progeni
releas
target
mapk
signal
pathway
vitro
addit
pretreat
could
reduc
viral
titer
within
heart
improv
patholog
alter
clinic
outcom
mous
model
infect
find
suggest
may
serv
potenti
therapeut
agent
treatment
diseas
studi
detect
dynam
express
mapk
signal
hela
cell
line
commonli
use
studi
compar
observ
earlier
time
point
express
hela
cell
dramat
upregul
h
follow
infect
wherea
protein
level
phosphoryl
downstream
target
includ
remark
decreas
accordingli
suggest
associ
mapk
signal
context
infect
result
luciferas
report
assay
confirm
potenti
target
consist
previou
report
find
indic
infect
induc
upregul
host
cell
lead
suppress
mapk
signal
follow
intracellular
replic
process
viru
releas
complet
final
stage
viral
life
cycl
signific
reduct
amount
releas
viru
respons
inhibitor
observ
h
postinfect
suggest
activ
mapk
signal
indispens
life
cycl
similar
result
also
observ
infect
cell
overexpress
compar
control
mirna
first
h
post
infect
persist
least
h
accompani
downregul
dephosphoryl
downstream
target
find
suggest
may
inhibit
progeni
releas
via
suppress
mapk
signal
support
previou
studi
inhibit
abil
compar
mapk
specif
inhibitor
could
reach
extent
mice
transduc
lenticon
follow
infect
use
control
group
mircon
shown
figur
intraven
inject
mice
level
increas
significantli
heart
b
viral
titer
detect
conduct
indic
time
point
heart
mice
treatment
n
viral
titer
decreas
compar
control
group
c
western
blot
mapk
phsp
express
heart
mice
transduc
gapdh
load
control
group
shown
repres
result
independ
test
tunel
assay
perform
day
post
infect
percentag
tunel
posit
cell
sampl
shown
repres
imag
shown
origin
magnif
e
immunohistochemistri
cleavedcaspas
tenfold
improt
viral
control
process
investig
whether
inhibitori
effect
progeni
releas
due
suppress
replic
detect
viral
capsid
protein
express
well
viral
load
within
infect
hela
cell
signific
chang
express
viral
load
observ
infect
cell
overexpress
control
mirna
suggest
might
affect
replic
infect
cell
least
within
h
post
infect
decreas
viral
progeni
releas
may
result
inhibit
host
cell
apoptosi
specul
might
protect
infect
cell
apoptosi
therefor
next
evalu
activ
cell
prolifer
infect
cell
found
significantli
inhibit
induc
effect
activ
promot
infect
cell
prolifer
doseand
timedepend
manner
also
detect
apoptosi
relat
cleavedcaspas
bax
express
infect
cell
apoptosi
also
evalu
annexinv
pi
stain
flow
cytometr
result
show
apoptosi
relat
protein
decreas
group
apoptosi
rate
also
declin
suggest
might
protect
host
cell
apoptosi
lead
improv
cell
surviv
previou
studi
show
overexpress
antiapoptot
protein
treatment
gener
caspas
inhibitor
prevent
viru
progeni
releas
h
follow
infect
indic
host
cell
apoptosi
facilit
progeni
releas
infect
cell
thu
inhibitori
effect
host
cell
apoptosi
might
contribut
decreas
viral
releas
least
initi
stage
viral
infect
wellestablish
close
associ
pathogenesi
cardiovascular
diseas
due
abund
cardiovascular
system
frequent
alter
develop
diseas
howev
whether
favor
unfavor
cardiovascular
system
remain
controversi
may
partial
due
differ
mous
strain
use
studi
present
studi
establish
infect
model
use
male
balbc
mice
observ
significantli
reduc
titer
suppress
mapk
signal
heart
tissu
mice
agreement
vitro
data
addit
mice
pretreat
exhibit
improv
patholog
alter
decreas
percentag
apoptosi
apoptosi
relat
cleavedcaspas
express
heart
import
treatment
also
prolong
surviv
time
data
suggest
may
benefici
host
infect
howev
due
insuffici
fund
support
includ
knockout
mous
model
studi
provid
convinc
evid
need
address
futur
conclus
present
studi
reveal
protect
role
infect
target
mapk
signal
pathway
vitro
vivo
viral
inhibit
attribut
inhibit
cell
apoptosi
process
result
provid
potenti
therapeut
agent
prevent
treatment
diseas
abbrevi
coxsackieviru
group
b
mirna
microrna
mapk
mitogenactiv
protein
kinas
heat
shock
protein
moi
multipl
infect
sirna
small
interfer
rna
utr
untransl
region
viral
protein
